Tachmed aiming to make healthcare more accessible
Tachmed is looking to transform access to healthcare through technology. The company’s CEO, Paul Christie,…
The Covid-19 pandemic began as a few scattered cases in China, but within months, the respiratory infection had swept the world. The years 2020 and 2021 turned into a rollercoaster ride for the world’s population, with millions of people dead, livelihoods destroyed, and movement between countries plummeting.
Despite the strained situation, academic researchers and biotech and pharma companies globally have come together to develop protective vaccines and treatments against Covid-19. While we still have a long road ahead before this pandemic is declared over, the life sciences industry is bringing us closer to this moment with every new discovery, trial result, and fundraise. Read on to learn about the latest research, investments, trends, and pipeline developments.
European Biotech Industry Report 2021: A Year of European Biotechnology
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations in the biotech and pharma industry.
Go to ReportTachmed is looking to transform access to healthcare through technology. The company’s CEO, Paul Christie,…
From a small biotech start-up firm in Allentown, Pennsylvania, two scientists are leading their team…
Ascletis Pharma Inc. has announced positive topline results from its phase I multiple ascending dose…
MetrioPharm AG, a Swiss pharmaceutical company developing drugs for inflammatory diseases, has announced topline data…
ExPLoRNA Therapeutics, a Polish biotech company working on mRNA vaccines and therapeutics, has received funding…
Tetra Bio-Pharma Inc. a leader in cannabinoid-derived drug discovery and development announced today significant results…
Pictor, a global leader in immunodiagnostics, has announced a $5 million funding round to help…
With the help of artificial intelligence (AI), researchers at Chalmers University of Technology in Sweden…
Ascletis Pharma Inc. has revealed that the U.S. Food and Drug Administration (FDA) has approved…
All approved antibody therapies for Covid-19 are ineffective against the Omicron sub-lineage BQ.1.1. That’s the…
Tevogen Bio is set to study the potential therapeutic use of its investigational Covid-19 T…
Viruses causing influenza and COVID-19 continually evolve to escape our vaccine protections. The French firm…